The Institute for Clinical and Economic Review (ICER) on Jan. 31 published an updated version of its value assessment framework to be used in future drug assessments.
According to a press release, the updates are “based on ICER’s ongoing efforts to learn from patient groups and others about how to build a unique approach to value assessment.”
“ICER’s value assessment framework has one main goal: to create a clear picture of what we are trying to accomplish and how we go about it,” ICER President Steven Pearson said. “We want the framework to help empower patients and others to fully participate in every stage of our work, because only with that engagement will we really meet the ultimate goal of moving our health care system toward a future of fair pricing, fair access, and sustainable innovation.”
To read the updated framework, click here.